What is the optimal management for a 37-year-old female with right lower quadrant pain, adenomyosis, moderate-to-severe lumbar arthritis, menstrual-related exacerbation of pain, and constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Adenomyosis with Menstrual-Related RLQ Pain and Constipation

This patient's menstrual-related RLQ pain with adenomyosis and constipation should be managed with a levonorgestrel-releasing intrauterine system (LNG-IUS) as first-line therapy, combined with NSAIDs for pain control and aggressive constipation management. 1, 2

Clinical Reasoning

The key diagnostic features here are:

  • Cyclical RLQ pain worsening with menses strongly suggests gynecologic etiology (adenomyosis) rather than appendicitis or other acute pathology
  • Negative ultrasound for appendicitis effectively rules out acute surgical abdomen 3
  • Confirmed adenomyosis on imaging provides the diagnosis
  • Constipation may be contributing to or exacerbating the pain, and can be associated with adenomyosis itself

The lumbar arthritis is likely a separate issue and should not drive the primary management of the RLQ pain given the clear menstrual relationship.

Treatment Algorithm

First-Line Medical Management

Hormonal suppression with LNG-IUS is the most evidence-based approach:

  • LNG-IUS has demonstrated effectiveness specifically for adenomyosis symptoms 1, 2, 4
  • Provides both pain relief and reduction in heavy menstrual bleeding
  • Allows fertility preservation if desired at age 37
  • Can be maintained long-term with minimal systemic side effects

Adjunctive Therapies

NSAIDs for pain control:

  • Use scheduled dosing during menstrual periods rather than as-needed
  • Addresses both adenomyosis-related pain and potential bowel-related discomfort 1

Aggressive constipation management:

  • Constipation worsening around menses suggests hormonal influence on bowel motility
  • Regular fiber supplementation, adequate hydration, and osmotic laxatives as needed
  • Consider that constipation may be contributing to RLQ pain independent of adenomyosis

Second-Line Options if LNG-IUS Fails

If symptoms persist after 3-6 months of LNG-IUS:

  • Dienogest (progestin therapy) - particularly effective for pain-dominant symptoms 5, 1, 4
  • Continuous oral contraceptives - suppresses menstruation entirely 4
  • GnRH antagonists for short-term use (3-6 months) followed by maintenance therapy 5, 4

Important Caveats

Rule out bowel endometriosis: While adenomyosis is confirmed, the combination of RLQ pain, constipation, and menstrual worsening could indicate concurrent bowel endometriosis 6, 7. If symptoms don't improve with hormonal therapy, consider:

  • Expanded protocol transvaginal ultrasound specifically for deep endometriosis 8
  • MRI pelvis with bowel preparation if not already done with endometriosis protocol
  • Gastroenterology referral if bowel symptoms predominate

The constipation pattern matters: Cyclical constipation worsening with menses suggests endometriosis involving the rectosigmoid, which occurs in up to 37% of endometriosis cases and can coexist with adenomyosis 7. Non-cyclical constipation is more likely related to the lumbar arthritis (reduced mobility, pain medications) or dietary factors.

Avoid premature surgery: Hysterectomy remains definitive treatment but should be reserved for medical therapy failures given the patient's age and potential fertility desires 1, 2. Surgical excision of adenomyosis is technically challenging with high recurrence rates.

Monitoring Response

Reassess at 3 months:

  • If significant improvement: continue current therapy
  • If partial improvement: optimize dosing or add adjunctive therapy
  • If no improvement: reconsider diagnosis (evaluate for bowel endometriosis) and escalate to second-line options

The lumbar arthritis should be managed separately by appropriate specialists, though NSAIDs used for adenomyosis may provide dual benefit.

References

Research

Guideline No. 437: Diagnosis and Management of Adenomyosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2023

Research

Adenomyosis: Diagnosis and Management.

American family physician, 2022

Guideline

acr appropriateness criteria® right lower quadrant pain: 2022 update.

Journal of the American College of Radiology, 2022

Research

Adenomyosis: a systematic review of medical treatment.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016

Research

Treatment selection for adenomyosis based on imaging findings and patient characteristics.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026

Research

Intestinal Endometriosis in a 38-Year-Old Woman.

Diagnostics (Basel, Switzerland), 2026

Guideline

acr appropriateness criteria® endometriosis.

Journal of the American College of Radiology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.